Our Pipeline

Focused Pipeline of Potential First-in-Class Aesthetic and Dermatological Solutions

Veradermics is advancing a focused pipeline of product candidates designed to address high-value dermatologic conditions with limited proven solutions, combining proven mechanisms with innovative formulations intended to optimize efficacy, safety, and patient convenience, starting with pattern hair loss – a condition impacting over 80 million people in the US alone.*

Vector
Vector
Vector
Veradermics New Pipeline Graphic

Beyond VDPHL01, we have created a portfolio utilizing our real-world experience as dermatologists to generate compelling pipeline assets, including exploratory assets in alopecia areata, common warts, molloscum contagiosum, that may be advanced in the future.

*Source: MedlinePlus.gov – Genetics, Androgenetic Alopecia, July 2023: 50M Men, 30M Women